RARA and osteosarcoma: It is known that all-trans retinoic acid (ATRA) induces differentiation of osteosarcoma cells regulated by retinoic acid receptor alpha (RARα), and RARα can be degraded through the ubiquitin–proteasome pathway to inhibit osteosarcoma cell differentiation.